<![CDATA[Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer]]>

<![CDATA[The panel surveys the clinical trial landscape and emerging therapeutic strategies for patients with recurrent endometrial cancer, particularly those who have progressed on frontline checkpoint inhibitor–based therapy.]]>

🔗 mentioned in this article

no entities indexed yet